Login / Signup

Real-world evidence of efficacy of pembrolizumab plus chemotherapy and nivolumab plus ipilimumab plus chemotherapy as initial treatment for advanced non-small cell lung cancer.

Ayami KanekoNobuaki KobayashKenji MiuraHiromi MatsumotoKohei SomekawaTomofumi HiroseYukihito KajitaAnna TanakaShuhei TeranishiYu SairenjiHidetoshi KawashimaKentaro YumotoToshinori TsukaharaNobuhiko FukudaRyuichi NishihiraKeisuke WatanabeNobuyuki HoritaYu HaraMakoto KudoNaoki MiyazawaTakeshi Kaneko
Published in: Thoracic cancer (2024)
In real-world practice, CP demonstrated superior PFS compared with CNI. These findings can inform treatment selection in advanced NSCLC.
Keyphrases
  • advanced non small cell lung cancer
  • epidermal growth factor receptor
  • healthcare
  • primary care
  • squamous cell carcinoma
  • combination therapy
  • radiation therapy
  • tyrosine kinase